1Lamm DL.Prophylaxis for recurrent transitional cell carcinoma[J].Urology,1991,37(Suppl 5):21.
2Nakagawa S,Kojima M,Takada H,et al.Short-duration bladder instillation therapy with pirarubicin for superficial bladder tumor based on pharmacodynamic study[J].Gan To Kagaku Ryoho,1992,19(11):1873.
3Kobayashi M,Sugaya Y,Yuzawa M,et al.Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue,anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor[J].Gan To Kagaku Ryoho,1998,25(11):1771.
4Okamura K,Ono Y,Kinukawa T,et al.Randomized study of single early instillation of (2″R)-4′-O-tetrahy-dropyranyl-doxorubicin for a single superficial bladder carcinoma[J].Cancer,2002,94(9):2363.
5]Kuroda K,Lshii N,Fukasawa K,et al.Short term intravesical instillation of pirarubicin (THP) in prophylaticc treatment after transurethral resection of superficial bladder tumor[J].I Hinyokika Kiyo,1998,44(8):547.
7Aikawa K,Lrisawa C,Mwraki O,et al.Postoperative intravesical instillation of THP for superficial bladder tumor:clinical results of prophylactic effect on the recurrence[J].Gan To Kagaku,1992,19(4):509.
